Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.